Trials / Sponsors / Lynkcell Europe
Lynkcell Europe
Academic / Other · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Phase I Clinical Trials Investigating the Potential Efficacy of Axitinib in Patients With a BRCA 1/2 Mutations Breast Cancer, Ovarian Cancer, Breast Neoplasms | Phase 1 | 2023-07-11 |
| No Longer Available | An Expanded Access Program to Axitinib is Available for Patients With Advanced Forms of Kidney Cancer (Ductal; Clear Cell Kidney Cancer, Kidney Cancer, Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations | — | — |